Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
95.21
+0.10 (0.11%)
At close: May 9, 2025, 4:00 PM
96.17
+0.96 (1.01%)
After-hours: May 9, 2025, 7:46 PM EDT
Zimmer Biomet Holdings Revenue
Zimmer Biomet Holdings had revenue of $1.91B in the quarter ending March 31, 2025, with 1.05% growth. This brings the company's revenue in the last twelve months to $7.70B, up 3.30% year-over-year. In the year 2024, Zimmer Biomet Holdings had annual revenue of $7.68B with 3.85% growth.
Revenue (ttm)
$7.70B
Revenue Growth
+3.30%
P/S Ratio
2.49
Revenue / Employee
$452,853
Employees
17,000
Market Cap
18.84B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.68B | 284.40M | 3.85% |
Dec 31, 2023 | 7.39B | 454.30M | 6.55% |
Dec 31, 2022 | 6.94B | 112.60M | 1.65% |
Dec 31, 2021 | 6.83B | 699.80M | 11.42% |
Dec 31, 2020 | 6.13B | -1.85B | -23.24% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
ZBH News
- 3 days ago - These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results - Benzinga
- 4 days ago - Zimmer Biomet: Stronger Cash Flows Needed Before The Stock Rebounds - Seeking Alpha
- 4 days ago - Hip Implant Maker Zimmer Biomet Cuts Annual Profit Forecast On Paragon 28 Deal - Benzinga
- 5 days ago - Zimmer Biomet Holdings, Inc. (ZBH) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Zimmer Biomet lowers 2025 profit forecast on acquisition costs, tariff uncertainty - Reuters
- 5 days ago - Zimmer Biomet Announces First Quarter 2025 Financial Results - PRNewsWire
- 19 days ago - Zimmer Biomet Completes Acquisition of Paragon 28 - PRNewsWire
- 4 weeks ago - Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2025 Financial Results - PRNewsWire